Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale VP Finance & Accounting sold 6,607 shares at $14.00 ($92,498)
  5. 4 Open-market sale See Remarks sold 10,000 shares at $12.08 ($120,826)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Option exercise Chief Scientific Officer acquired 6,350 shares (option exercise)
  10. 4 Open-market sale Chief Scientific Officer sold 2,951 shares at $20.00 ($59,020)
  11. 4 Open-market sale See Remarks sold 2,500 shares at $20.00 ($50,000)
  12. 4 Open-market sale SVP Clinical Development sold 1,071 shares at $18.30 ($19,599)
  13. 4 Open-market sale Chief Scientific Officer sold 141 shares at $20.00 ($2,820)
  14. 4 Open-market sale SVP Clinical Development sold 1,459 shares at $22.00 ($32,098)
  15. 4 Open-market sale See Remarks sold 2,500 shares at $20.80 ($51,992)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 12 · 221 filings